Operating Lease, Right-of-Use Asset in USD of AGILE THERAPEUTICS INC from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Agile Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q2 2024.
  • Agile Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $255K, a 54.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $255K -$303K -54.3% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $335K -$293K -46.7% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $412K -$283K -40.7% 31 Dec 2023 10-Q 12 Aug 2024
Q3 2023 $486K -$275K -36.1% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $558K -$267K -32.4% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $628K -$260K -29.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $695K -$254K -26.8% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $761K +$724K +1957% 30 Sep 2022 10-K 23 Mar 2023
Q2 2022 $825K +$753K +1046% 30 Jun 2022 10-K 23 Mar 2023
Q1 2022 $888K +$782K +738% 31 Mar 2022 10-K 23 Mar 2023
Q4 2021 $949K +$811K +588% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $37K +$6K +19.4% 30 Sep 2021 10-Q/A 30 Dec 2021
Q2 2021 $72K 30 Jun 2021 10-Q 26 Jul 2021
Q1 2021 $106K 31 Mar 2021 10-Q 04 May 2021
Q4 2020 $138K -$20K -12.7% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $31K -$183K -85.5% 30 Sep 2020 10-Q 12 Nov 2020
Q4 2019 $158K +$140K +778% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 $214K 30 Sep 2019 10-Q 28 Oct 2019
Q2 2019 $250K 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $284K 31 Mar 2019 10-Q 03 May 2019
Q4 2018 $18K 31 Dec 2018 10-Q 28 Oct 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.